Process for the preparation of HMG-CoA reductase inhibitors intermediates
US4611081A · kind A · utility
3Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 1985 |
| Grant date | Sep 9, 1986 |
| Priority date | — |
| Expiry date | Jul 5, 2005 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C69/76
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A novel process for intermediates in the synthesis and hypercholesterolemic compounds of the HMG-CoA reductase type of the following general formula (1): ##STR1## involving an enantioselective aldol condensation is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.